{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:12:03Z","timestamp":1788448323342,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45361-z","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:44:18Z","timestamp":1775461458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Machine learning-driven drug repurposing for HER2-positive breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Basavana Gowda Hosur","family":"Dinesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Ganjipete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandral Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar Nayak","family":"Ammunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Kunjiappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabu Kumar","family":"Seetharaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohankumar","family":"Ramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumarappan","family":"Chidambaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"45361_CR1","doi-asserted-by":"crossref","unstructured":"Kumari, S. Identification of breast cancer biomarkers through bioinformatics approach. Lett. Drug Des. Discovery, : p. 100101. (2025).","DOI":"10.1016\/j.lddd.2025.100101"},{"issue":"3","key":"45361_CR2","first-page":"287","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J. Natl. Cancer Cent. 5 (3), 287 (2025).","journal-title":"J. Natl. Cancer Cent."},{"key":"45361_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold, M. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 66, 15\u201323 (2022).","journal-title":"Breast"},{"issue":"4","key":"45361_CR4","doi-asserted-by":"publisher","first-page":"e70016","DOI":"10.1002\/cai2.70016","volume":"4","author":"Z Qu","year":"2025","unstructured":"Qu, Z. et al. Global, Regional, and National Burden of Breast Cancer in Adolescents and Young Adults Aged 15\u201339 Years From 1990 to 2021 Based on the Global Burden of Disease Study 2021. Cancer Innov. 4 (4), e70016 (2025).","journal-title":"Cancer Innov."},{"issue":"10","key":"45361_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/curroncol32100553","volume":"32","author":"J Diaz-Martinez","year":"2025","unstructured":"Diaz-Martinez, J. et al. Beyond Biology: Uncovering Structural and Sociocultural Predictors of Breast Cancer Incidence Worldwide. Curr. Oncol. 32 (10), 553 (2025).","journal-title":"Curr. Oncol."},{"issue":"1","key":"45361_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong, X. et al. Breast cancer: pathogenesis and treatments. Signal. Transduct. Target. therapy. 10 (1), 49 (2025).","journal-title":"Signal. Transduct. Target. therapy"},{"key":"45361_CR7","unstructured":"Petrucelli, N., Daly, M. B. & Pal, T. BRCA1-and BRCA2-associated hereditary breast and ovarian cancer. (2022)."},{"issue":"1","key":"45361_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41416-021-01392-z","volume":"125","author":"S Tin Tin","year":"2021","unstructured":"Tin Tin, S., Reeves, G. K. & Key, T. J. Endogenous hormones and risk of invasive breast cancer in pre-and post-menopausal women: findings from the UK Biobank. Br. J. Cancer. 125 (1), 126\u2013134 (2021).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"45361_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cmet.2024.01.002","volume":"36","author":"AR Nichols","year":"2024","unstructured":"Nichols, A. R., Chavarro, J. E. & Oken, E. Reproductive risk factors across the female lifecourse and later metabolic health. Cell Metabol. 36 (2), 240\u2013262 (2024).","journal-title":"Cell Metabol."},{"key":"45361_CR10","doi-asserted-by":"crossref","unstructured":"Dinesh, B. G. H. et al. Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy (Current Pharmaceutical Design, 2025).","DOI":"10.2174\/0113816128357976250122042633"},{"key":"45361_CR11","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.ctrv.2021.102286","volume":"100","author":"E Hamilton","year":"2021","unstructured":"Hamilton, E. et al. Targeting HER2 heterogeneity in breast cancer. Cancer Treat. Rev. 100, 102286 (2021).","journal-title":"Cancer Treat. Rev."},{"key":"45361_CR12","doi-asserted-by":"crossref","unstructured":"Marchi\u00f2, C. et al. Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond. in Seminars in cancer biology (Elsevier, 2021).","DOI":"10.1016\/j.semcancer.2020.02.016"},{"issue":"9","key":"45361_CR13","doi-asserted-by":"publisher","first-page":"15196","DOI":"10.3390\/molecules190915196","volume":"19","author":"RL Schroeder","year":"2014","unstructured":"Schroeder, R. L., Stevens, C. L. & Sridhar, J. Small molecule tyrosine kinase inhibitors of ErbB2\/HER2\/Neu in the treatment of aggressive breast cancer. Molecules 19 (9), 15196\u201315212 (2014).","journal-title":"Molecules"},{"issue":"2","key":"45361_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4161\/cam.4.2.11191","volume":"4","author":"F Cymer","year":"2010","unstructured":"Cymer, F. & Schneider, D. Transmembrane helix-helix interactions involved in ErbB receptor signalling. Cell Adhes. Migr. 4 (2), 299\u2013312 (2010).","journal-title":"Cell Adhes. Migr."},{"issue":"7","key":"45361_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/genes15070903","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng, X. A comprehensive review of HER2 in cancer biology and therapeutics. Genes 15 (7), 903 (2024).","journal-title":"Genes"},{"key":"45361_CR16","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.drup.2023.101042","volume":"73","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Inhibition of NF-\u03baB signalling unveils novel strategies to overcome drug resistance in cancers. Drug Resist. Updates. 73, 101042 (2024).","journal-title":"Drug Resist. Updates"},{"key":"45361_CR17","doi-asserted-by":"publisher","first-page":"964824","DOI":"10.3389\/fonc.2022.964824","volume":"12","author":"CY Chow","year":"2022","unstructured":"Chow, C. Y. et al. Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers. Front. Oncol. 12, 964824 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"45361_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41523-021-00265-1","volume":"7","author":"I Schlam","year":"2021","unstructured":"Schlam, I. & Swain, S. M. HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now. NPJ breast cancer. 7 (1), 56 (2021).","journal-title":"NPJ breast cancer"},{"issue":"6","key":"45361_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cancers11060737","volume":"11","author":"DM Collins","year":"2019","unstructured":"Collins, D. M. et al. Preclinical characteristics of the irreversible pan-HER kinase inhibitor neratinib compared with lapatinib: implications for the treatment of HER2-positive and HER2-mutated breast cancer. Cancers 11 (6), 737 (2019).","journal-title":"Cancers"},{"key":"45361_CR20","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.adcanc.2022.100065","volume":"6","author":"V Tripathi","year":"2022","unstructured":"Tripathi, V. et al. Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer. Adv. Cancer Biology-Metastasis. 6, 100065 (2022).","journal-title":"Adv. Cancer Biology-Metastasis"},{"key":"45361_CR21","doi-asserted-by":"publisher","first-page":"109744","DOI":"10.1016\/j.compbiomed.2025.109744","volume":"187","author":"A Sultana","year":"2025","unstructured":"Sultana, A. et al. Unraveling the molecular landscape of non-small cell lung cancer: Integrating bioinformatics and statistical approaches to identify biomarkers and drug repurposing. Comput. Biol. Med. 187, 109744 (2025).","journal-title":"Comput. Biol. Med."},{"key":"45361_CR22","doi-asserted-by":"crossref","unstructured":"Matthews, B. et al. Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer. Mol. Therapy Oncol., 32(4). (2024).","DOI":"10.1016\/j.omton.2024.200911"},{"key":"45361_CR23","first-page":"100249","volume":"7","author":"DM Gaber","year":"2024","unstructured":"Gaber, D. M. et al. A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessment. Int. J. Pharmaceutics: X. 7, 100249 (2024).","journal-title":"Int. J. Pharmaceutics: X"},{"issue":"5","key":"45361_CR24","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/app15052798","volume":"15","author":"S Herr\u00e1iz-Gil","year":"2025","unstructured":"Herr\u00e1iz-Gil, S. et al. Artificial intelligence-based methods for drug repurposing and development in cancer. Appl. Sci. 15 (5), 2798 (2025).","journal-title":"Appl. Sci."},{"issue":"1","key":"45361_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/curroncol30010055","volume":"30","author":"G Doumat","year":"2023","unstructured":"Doumat, G. et al. Drug repurposing in non-small cell lung carcinoma: old solutions for new problems. Curr. Oncol. 30 (1), 704\u2013719 (2023).","journal-title":"Curr. Oncol."},{"key":"45361_CR26","doi-asserted-by":"crossref","unstructured":"Shahrior, R. et al. In-silico investigation integrated with machine learning to identify potential inhibitors targeting AKT2: Key driver of cancer cell progression and metastasis p. 108793 (Computer Methods and Programs in Biomedicine, 2025).","DOI":"10.1016\/j.cmpb.2025.108793"},{"key":"45361_CR27","doi-asserted-by":"crossref","unstructured":"Vijara, N. et al. Machine Learning-Driven QSAR Modeling of Anti-Cancer Activity from a Rationally Designed Synthetic Flavone Library. ChemMedChem, : p. e202500143. (2025).","DOI":"10.1002\/cmdc.202500143"},{"issue":"12","key":"45361_CR28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1517\/17460441.2015.1083006","volume":"10","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Quantitative structure\u2013activity relationship: promising advances in drug discovery platforms. Expert Opin. Drug Discov. 10 (12), 1283\u20131300 (2015).","journal-title":"Expert Opin. Drug Discov."},{"issue":"22","key":"45361_CR29","doi-asserted-by":"publisher","first-page":"12445","DOI":"10.1080\/07391102.2023.2175263","volume":"41","author":"R Choudhary","year":"2023","unstructured":"Choudhary, R. et al. Machine learning facilitated structural activity relationship approach for the discovery of novel inhibitors targeting EGFR. J. Biomol. Struct. Dynamics. 41 (22), 12445\u201312463 (2023).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"45361_CR30","doi-asserted-by":"crossref","unstructured":"Javid, S. et al. Machine learning & deep learning tools in pharmaceutical sciences: A comprehensive review (Intelligent Pharmacy, 2025).","DOI":"10.1016\/j.ipha.2024.11.003"},{"issue":"D1","key":"45361_CR31","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44 (D1), D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"45361_CR32","doi-asserted-by":"crossref","unstructured":"Todeschini, R. & Consonni, V. Handbook of molecular descriptors (Wiley, 2008).","DOI":"10.1007\/978-1-4020-9783-6_3"},{"issue":"1","key":"45361_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13321-018-0258-y","volume":"10","author":"H Moriwaki","year":"2018","unstructured":"Moriwaki, H. et al. Mordred: a molecular descriptor calculator. J. Cheminform. 10 (1), 4 (2018).","journal-title":"J. Cheminform."},{"issue":"14","key":"45361_CR34","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.3390\/molecules30142992","volume":"30","author":"MF Akmal","year":"2025","unstructured":"Akmal, M. F. & Wong, M. W. Selective Cleaning Enhances Machine Learning Accuracy for Drug Repurposing: Multiscale Discovery of MDM2 Inhibitors. Molecules 30 (14), 2992 (2025).","journal-title":"Molecules"},{"issue":"6","key":"45361_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3136625","volume":"50","author":"J Li","year":"2017","unstructured":"Li, J. et al. Feature selection: A data perspective. ACM Comput. Surv. (CSUR). 50 (6), 1\u201345 (2017).","journal-title":"ACM Comput. Surv. (CSUR)"},{"issue":"7","key":"45361_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1517\/17460441.2010.492827","volume":"5","author":"C Nantasenamat","year":"2010","unstructured":"Nantasenamat, C., Isarankura-Na-Ayudhya, C. & Prachayasittikul, V. Advances in computational methods to predict the biological activity of compounds. Expert Opin. Drug Discov. 5 (7), 633\u2013654 (2010).","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"45361_CR37","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41598-020-80758-4","volume":"11","author":"I Abdelbaky","year":"2021","unstructured":"Abdelbaky, I., Tayara, H. & Chong, K. T. Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets. Sci. Rep. 11 (1), 706 (2021).","journal-title":"Sci. Rep."},{"key":"45361_CR38","doi-asserted-by":"crossref","unstructured":"Rafi, T. H. & Farhan, F. A performance evaluation of machine learning models on human activity identification (hai). in International Conference on Soft Computing and Pattern Recognition. Springer. (2020).","DOI":"10.1007\/978-3-030-73689-7_25"},{"key":"45361_CR39","doi-asserted-by":"publisher","first-page":"102406","DOI":"10.1016\/j.ecoinf.2023.102406","volume":"79","author":"BB Hanberry","year":"2024","unstructured":"Hanberry, B. B. Practical guide for retaining correlated climate variables and unthinned samples in species distribution modeling, using random forests. Ecol. Inf. 79, 102406 (2024).","journal-title":"Ecol. Inf."},{"key":"45361_CR40","unstructured":"Seo, S. A review and comparison of methods for detecting outliers in univariate data sets (University of Pittsburgh, 2006)."},{"issue":"8","key":"45361_CR41","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1021\/acs.jcim.3c02039","volume":"64","author":"A Leniak","year":"2024","unstructured":"Leniak, A., Pietrus, W. & Kurczab, R. From NMR to AI: designing a novel chemical representation to enhance machine learning predictions of physicochemical properties. J. Chem. Inf. Model. 64 (8), 3302\u20133321 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"45361_CR42","doi-asserted-by":"crossref","unstructured":"Khera, P. & Kumar, N. Novel machine learning-based hybrid strategy for severity assessment of Parkinson\u2019s disorders Vol. 60, p. 811\u2013828 (Medical & Biological Engineering & Computing, 2022). 3.","DOI":"10.1007\/s11517-022-02518-y"},{"issue":"9","key":"45361_CR43","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/sym12091424","volume":"12","author":"S Alabdulwahab","year":"2020","unstructured":"Alabdulwahab, S. & Moon, B. Feature selection methods simultaneously improve the detection accuracy and model building time of machine learning classifiers. Symmetry 12 (9), 1424 (2020).","journal-title":"Symmetry"},{"key":"45361_CR44","doi-asserted-by":"crossref","unstructured":"Guo, Q., Hernandez-Hernandez, S. & Ballester, P. J. Scaffold splits overestimate virtual screening performance. in International Conference on Artificial Neural Networks. Springer. (2024).","DOI":"10.1007\/978-3-031-72359-9_5"},{"key":"45361_CR45","doi-asserted-by":"crossref","unstructured":"Vastrad, C. Predictive comparative QSAR analysis of As 5-nitofuran-2-YL derivatives myco bacterium tuberculosis H37RV inhibitors bacterium tuberculosis H37RV inhibitors. arXiv preprint arXiv:1312.2841, 2013.","DOI":"10.5121\/hiij.2013.2404"},{"issue":"1","key":"45361_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1145\/1656274.1656278","volume":"11","author":"M Hall","year":"2009","unstructured":"Hall, M. et al. The WEKA data mining software: an update. ACM SIGKDD explorations Newsl. 11 (1), 10\u201318 (2009).","journal-title":"ACM SIGKDD explorations Newsl."},{"issue":"6","key":"45361_CR47","first-page":"493","volume":"2","author":"AL Boulesteix","year":"2012","unstructured":"Boulesteix, A. L. et al. Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics. Wiley Interdisciplinary Reviews: Data Min. Knowl. Discovery. 2 (6), 493\u2013507 (2012).","journal-title":"Wiley Interdisciplinary Reviews: Data Min. Knowl. Discovery"},{"key":"45361_CR48","unstructured":"Siu, W. C. et al. Introduction to Random Tree and Random Forests for Fast Signal Processing and Object Classification, in Learning Approaches in Signal Processing. Jenny Stanford Publishing. pp. 27-76. (2018)."},{"issue":"5","key":"45361_CR49","doi-asserted-by":"publisher","first-page":"855","DOI":"10.18576\/amis\/140513","volume":"14","author":"M Sakr","year":"2020","unstructured":"Sakr, M. et al. Machine learning for breast cancer classification using k-star algorithm. Appl. Math. Inform. Sci. 14 (5), 855\u2013863 (2020).","journal-title":"Appl. Math. Inform. Sci."},{"issue":"3","key":"45361_CR50","first-page":"2711","volume":"35","author":"S Zhang","year":"2021","unstructured":"Zhang, S. & Li, J. KNN classification with one-step computation. IEEE Trans. Knowl. Data Eng. 35 (3), 2711\u20132723 (2021).","journal-title":"IEEE Trans. Knowl. Data Eng."},{"issue":"6","key":"45361_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17010\/ijcs\/2021\/v6\/i6\/167641","volume":"6","author":"AS Saud","year":"2021","unstructured":"Saud, A. S., Shakya, S. & Neupane, B. Analysis of depth of entropy and GINI index based decision trees for predicting diabetes. Indian J. Comput. Sci. 6 (6), 19\u201328 (2021).","journal-title":"Indian J. Comput. Sci."},{"issue":"7","key":"45361_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10462-025-11198-7","volume":"58","author":"J Terven","year":"2025","unstructured":"Terven, J. et al. A comprehensive survey of loss functions and metrics in deep learning. Artif. Intell. Rev. 58 (7), 195 (2025).","journal-title":"Artif. Intell. Rev."},{"issue":"1","key":"45361_CR53","doi-asserted-by":"publisher","first-page":"21632","DOI":"10.1038\/s41598-025-04129-7","volume":"15","author":"HH Alhassan","year":"2025","unstructured":"Alhassan, H. H. Integrative machine learning and molecular simulation approaches identify GSK3\u03b2 inhibitors for neurodegenerative disease therapy. Sci. Rep. 15 (1), 21632 (2025).","journal-title":"Sci. Rep."},{"issue":"5","key":"45361_CR54","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.3390\/ijms25052646","volume":"25","author":"M Nwadiugwu","year":"2024","unstructured":"Nwadiugwu, M. et al. Beyond amyloid: a machine learning-driven approach reveals properties of potent GSK-3\u03b2 inhibitors targeting neurofibrillary tangles. Int. J. Mol. Sci. 25 (5), 2646 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"45361_CR55","doi-asserted-by":"publisher","first-page":"31901","DOI":"10.1038\/s41598-025-17733-4","volume":"15","author":"D Hanumanthappa","year":"2025","unstructured":"Hanumanthappa, D. et al. Computational insights and experimental breakthroughs in identifying next-generation acetylcholinesterase inhibitors. Sci. Rep. 15 (1), 31901 (2025).","journal-title":"Sci. Rep."},{"issue":"2","key":"45361_CR56","doi-asserted-by":"publisher","first-page":"e2875","DOI":"10.1002\/jmr.2875","volume":"34","author":"D Salha","year":"2021","unstructured":"Salha, D., Anda\u00e7, M. & Denizli, A. Molecular docking of metal ion immobilized ligands to proteins in affinity chromatography. J. Mol. Recognit. 34 (2), e2875 (2021).","journal-title":"J. Mol. Recognit."},{"key":"45361_CR57","doi-asserted-by":"crossref","unstructured":"Shajan, S. R. O. et al. Folic Acid-Conjugated Ferulic Acid-Entangled Single-Walled Carbon Nanotubes: A Targeted Therapeutic Approach for Effective Breast Cancer Treatment. J. Drug Deliv. Sci. Technol., : p. 107111. (2025).","DOI":"10.1016\/j.jddst.2025.107111"},{"issue":"1","key":"45361_CR58","doi-asserted-by":"publisher","first-page":"10885","DOI":"10.1038\/s41598-025-95806-0","volume":"15","author":"SD Almeida","year":"2025","unstructured":"Almeida, S. D. et al. Development and evaluation of S-carboxymethyl-L-cystine-loaded solid lipid nanoparticles for Parkinson\u2019s disease in murine and zebrafish models. Sci. Rep. 15 (1), 10885 (2025).","journal-title":"Sci. Rep."},{"issue":"8","key":"45361_CR59","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s10876-024-02694-x","volume":"35","author":"GK Radhakrishna","year":"2024","unstructured":"Radhakrishna, G. K. et al. Capsaicin-entangled multi-walled carbon nanotubes against breast cancer: A theoretical and experimental approach. J. Cluster Sci. 35 (8), 2849\u20132869 (2024).","journal-title":"J. Cluster Sci."},{"issue":"11","key":"45361_CR60","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.3390\/molecules28114541","volume":"28","author":"S Vellur","year":"2023","unstructured":"Vellur, S. et al. An in silico molecular modelling-based prediction of potential Keap1 inhibitors from Hemidesmus indicus (L.) R. Br. against oxidative-stress-induced diseases. Molecules 28 (11), 4541 (2023).","journal-title":"Molecules"},{"issue":"17","key":"45361_CR61","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1080\/07391102.2021.1902394","volume":"40","author":"B Kumar","year":"2022","unstructured":"Kumar, B. et al. In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (Mpro) structure of SARS-CoV-2. J. Biomol. Struct. Dynamics. 40 (17), 7796\u20137814 (2022).","journal-title":"J. Biomol. Struct. Dynamics"},{"issue":"1","key":"45361_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong, J. et al. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J. Cheminform. 10 (1), 29 (2018).","journal-title":"J. Cheminform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45361-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:02:28Z","timestamp":1779368548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45361"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45361-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15868"}}